Privium Fund Management’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10M | Buy |
4,997,562
+11,929
| +0.2% | +$24K | 2.17% | 10 |
|
|
2025
Q1 | $6.63M | Hold |
4,985,633
| – | – | 1.73% | 13 |
|
|
2024
Q4 | $13.2M | Sell |
4,985,633
-646,755
| -11% | -$1.71M | 2.99% | 7 |
|
|
2024
Q3 | $10.3M | Buy |
5,632,388
+51,663
| +0.9% | +$94K | 2.55% | 10 |
|
|
2024
Q2 | $9.21M | Buy |
5,580,725
+236,279
| +4% | +$390K | 2.35% | 11 |
|
|
2024
Q1 | $12.2M | Hold |
5,344,446
| – | – | 3.27% | 7 |
|
|
2023
Q4 | $11.1M | Hold |
5,344,446
| – | – | 3.1% | 8 |
|
|
2023
Q3 | $6.95M | Hold |
5,344,446
| – | – | 2.07% | 14 |
|
|
2023
Q2 | $8.66M | Hold |
5,344,446
| – | – | 2.49% | 15 |
|
|
2023
Q1 | $11.4M | Hold |
5,344,446
| – | – | 3.82% | 6 |
|
|
2022
Q4 | $18M | Hold |
5,344,446
| – | – | 6.83% | 4 |
|
|
2022
Q3 | $4.04M | Hold |
5,344,446
| – | – | 1.47% | 22 |
|
|
2022
Q2 | $4.16M | Buy |
5,344,446
+100,000
| +2% | +$77.8K | 1.38% | 23 |
|
|
2022
Q1 | $4.75M | Buy |
5,244,446
+478,787
| +10% | +$433K | 1.05% | 26 |
|
|
2021
Q4 | $38.9M | Buy |
+4,765,659
| New | +$38.9M | 7.72% | 2 |
|